Persistent Systems- Annual Revenue Grows 29.4 % and PAT Grows 32.3 %
FY13 Dividend Rs. 9 per share
Persistent Systems Launches PaxPharma, Compliance-Based Design to Print Automation for the Pharmaceutical Industry
PHILADELPHIA, PA — (Marketwire) — 02/26/13 — (BOMBAY: PERSISTENT) (NSE: PERSISTENT), the global leader in software product and technology services, today announced the immediate availability of PaxPharma, a compliance-based, Design to Print (D2P) automation solution designed specifically for pharmaceutical packaging and product lifecycle management (PLM). The company unveiled the solution at this year-s conference being held February 26 and 27 at the Hilton Philadelphia City Avenue Hotel.